Sofosbuvir / velpatasvir and Fatigue: What Users Say (Page 4)
Brand names: Epclusa
Reviews for Sofosbuvir / velpatasvir
- Anonymous
- Taken for 1 to 6 months
- August 21, 2019
For Hepatitis C "Last dose 7/23/19. Side effects: most major, extreme hair loss, then fatigue, headaches, anxiety, and depression. Hair fall slowing. I hope it grows back."
- ABA...
- May 26, 2017
For Hepatitis C "I've experienced muscular and joint pains, especially in the afternoons - shoulders especially. Fatigue seems to be the most persistent complaint."
Frequently asked questions
- What are the new drugs for the treatment of hepatitis C?
- How much does Epclusa cost?
- Does Epclusa cure Hep C, what is the success rate?
- Can you drink alcohol while taking Epclusa?
- Prb...
- Taken for less than 1 month
- May 9, 2019
For Hepatitis C "Thank everyone for sharing their experiences about Epclusa. This is my 3rd night taking it. I definitely agree with the fatigue. I will keep you posted."
- Roc...
- Taken for 1 to 6 months
- December 12, 2020
For Hepatitis C "Experienced some headaches and fatigue."
Are you taking this medicine?
Your review helps others make informed decisions.More about sofosbuvir / velpatasvir
- sofosbuvir/velpatasvir consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (419)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: antiviral combinations
- En español
For Hepatitis C "Well, I was diagnosed with Hep C and prescribed Epclusa. I am now 10 weeks into my treatment, and I feel absolutely fantastic. My energy level is back, I now get out of bed at 8 o'clock most days. The side effects for me were mostly a lack of energy that lasted for a couple of weeks and a bit of nausea, both were easy to get through, and now I feel like a new person. I would recommend this treatment to everyone who gets the offer. I am now 8 months clean from IV meth and heroin, and this medication has been great for me. To anyone starting treatment, good luck, you can do it."